US Market for Cardiac Surgery and Heart Valve Devices 2018 - MedView

  • ID: 4435252
  • Report
  • Region: United States
  • 366 pages
  • iData Research
15 % OFF
until Oct 31st 2018
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific
  • Cryolife
  • Karl Storz
  • Microline Surgical
  • SentreHeart
  • MORE
Cardiac surgery involves the heart and the great vessels connected to the heart. It is often performed to treat ischemic heart disease, congenital heart disease, valvular heart disease as well as heart transplantation. The first cardiac surgeries were performed in the 19th century on the pericardium, the sac that surrounds the heart. The first surgery on the heart itself was performed in 1895 in Oslo, Norway. Surgeon Axel Cappelen ligated the bleeding coronary artery of a 24-year-old patient who had been stabbed under his left arm.

The patient survived for over two days but later passed away due to infection from the procedure. Approximately one year afterwards, a successful operation was performed in Germany on another patient with a stabbing injury. There are many risks associated with performing cardiac surgery. Patients often suffer from neurological damage and strokes after procedures. Neurological damage is more common when an ONCAB procedure is performed; many patients suffer from post-perfusion syndrome, which is a combination of neurological conditions that can affect patients after surgery. These symptoms can be temporary or permanent.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific
  • Cryolife
  • Karl Storz
  • Microline Surgical
  • SentreHeart
  • MORE
EXECUTIVE SUMMARY
U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY

1. RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecasts and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.11 Coronary Artery Disease
2.1.12 Myocardial Infarction
2.1.13 Angina Pectoris
2.1.14 Heart Valve Disease
2.1.15 Congestive Heart Failure
U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS BY SEGMENT
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS
3.6 COMPANY PROFILES
3.6.1 Edwards Life Sciences
3.6.2 Medtronic
3.6.3 St. Jude Medical
3.6.4 MAQUET
3.6.5 Abiomed
3.6.6 HeartWare Inc
3.7 COMPANY SWOT ANALYSIS
3.7.1 Edwards Life Sciences
3.7.2 Medtronic
3.7.3 St. Jude Medical
3.7.4 MAQUET
3.7.5 Abiomed
3.7.6 HeartWare Inc.

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

List of Charts
Chart 1 1: Cardiac Surgery and Heart Valve Devices Market by Segment, U.S., 2014 – 2024
Chart 1 2: Cardiac Surgery and Heart Valve Devices Market Overview, U.S., 2017 & 2024
Chart 4 1: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 – 2024
Chart 4 2: Cardiac Surgery and Heart Valve Device Market Breakdown, U.S., 2017
Chart 4 3: Cardiac Surgery and Heart Valve Device Market Breakdown, U.S., 2024
Chart 4 4: Growth Rates by Segment, Cardiac Surgery and Heart Valve Device Market, U.S., 2014 – 2024
Chart 4 5: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017

List of Figures:
Figure 1 1: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (1 of 4)
Figure 1 2: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (2 of 4)
Figure 1 3: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (3 of 4)
Figure 1 4: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (4 of 4)
Figure 1 5: Companies Researched in this Report, U.S., 2017
Figure 1 6: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (1 of 4)
Figure 1 7: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (2 of 4)
Figure 1 8: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (3 of 4)
Figure 1 9: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (4 of 4)
Figure 1 10: Recent Events in the Cardiac Surgery and Heart Valve Devices Market, U.S., 2015 – 2017
Figure 1 11: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (1 of 4)
Figure 1 12: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (2 of 4)
Figure 1 13: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (3 of 4)
Figure 1 14: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (4 of 4)
Figure 1 15: Procedure Codes Investigated, U.S., 2017
Figure 1 16: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (1 of 2)
Figure 1 17: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (2 of 2)
Figure 1 18: Key Report Updates (1 of 2)
Figure 1 19: Key Report Updates (2 of 2)
Figure 1 20: Version History
Figure 4 1: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 – 2024 (US$M) (1 of 3)
Figure 4 2: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 – 2024 (US$M) (2 of 3)
Figure 4 3: Cardiac Surgery and Heart Valve Device Market by Segment, U.S., 2014 – 2024 (US$M) (3 of 3)
Figure 4 4: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2014 – 2024 (1 of 3)
Figure 4 5: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2014 – 2024 (2 of 3)
Figure 4 6: Cardiac Surgery and Heart Valve Device Market Growth by Segment, U.S., 2014 – 2024 (3 of 3)
Figure 4 7: Drivers and Limiters, Cardiac Surgery and Heart Valve Device Market, U.S., 2017
Figure 4 8: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 (1 of 3)
Figure 4 9: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 (2 of 3)
Figure 4 10: Leading Competitors, Cardiac Surgery and Heart Valve Device Market, U.S., 2017 (3 of 3)
Figure 4 11: SWOT Analysis, Edwards Life Sciences, 2017
Figure 4 12: SWOT Analysis, Medtronic, 2018
Figure 4 13: SWOT Analysis, St. Jude Medical, 2018
Figure 4 14: SWOT Analysis, MAQUET, 2018
Figure 4 15: SWOT Analysis, Abiomed, 2018
Figure 4 16: SWOT Analysis, HeartWare Inc, 2018
Figure 25 1: Press Release Summary
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Edwards Lifesciences
  • St. Jude Medical
  • Medtronic
  • Maquet
  • Abiomed
  • HeartWare Inc.
  • Sorin Group
  • Terumo
  • Abbott Laboratories
  • Teleflex Medical
  • Cardiac Assist
  • AtriCure
  • W.L. Gore
  • SynCardia
  • Boston Scientific
  • Cryolife
  • Berlin Heart
  • Cardica
  • Chase Medical
  • Genesee Biomedical
  • Karl Storz
  • LifeNet Health
  • Microline Surgical
  • Novadaq
  • On-X
  • Saphena Medical
  • SentreHeart
  • Vitalitec
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll